This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4q2k
From Proteopedia
(Difference between revisions)
| (5 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b== | ==Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b== | ||
| - | <StructureSection load='4q2k' size='340' side='right' caption='[[4q2k]], [[Resolution|resolution]] 2.20Å' scene=''> | + | <StructureSection load='4q2k' size='340' side='right'caption='[[4q2k]], [[Resolution|resolution]] 2.20Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4q2k]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4q2k]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4Q2K OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4Q2K FirstGlance]. <br> |
| - | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5BF:(11S)-4,9-DIOXO-N-[(2S)-1-OXO-3-PHENYLPROPAN-2-YL]-17,22-DIOXA-10,30-DIAZATETRACYCLO[21.2.2.2~13,16~.1~5,8~]TRIACONTA-1(25),5,7,13,15,23,26,28-OCTAENE-11-CARBOXAMIDE'>5BF</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5BF:(11S)-4,9-DIOXO-N-[(2S)-1-OXO-3-PHENYLPROPAN-2-YL]-17,22-DIOXA-10,30-DIAZATETRACYCLO[21.2.2.2~13,16~.1~5,8~]TRIACONTA-1(25),5,7,13,15,23,26,28-OCTAENE-11-CARBOXAMIDE'>5BF</scene></td></tr> | |
| - | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4q2k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4q2k OCA], [https://pdbe.org/4q2k PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4q2k RCSB], [https://www.ebi.ac.uk/pdbsum/4q2k PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4q2k ProSAT]</span></td></tr> |
| - | <table> | + | </table> |
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/CTRA_BOVIN CTRA_BOVIN] | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 15: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4q2k" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Chymotrypsin 3D structures|Chymotrypsin 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 20: | Line 27: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Bos taurus]] | [[Category: Bos taurus]] | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Abell | + | [[Category: Abell AD]] |
| - | [[Category: Bruning | + | [[Category: Bruning JB]] |
| - | [[Category: Chan | + | [[Category: Chan HY]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Bovine alpha chymotrypsin bound to a cyclic peptide inhibitor, 5b
| |||||||||||
